Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospitalgrid.32224.35, Boston, Massachusetts, USA.
Department of Medicine, Massachusetts General Hospitalgrid.32224.35, Boston, Massachusetts, USA.
mSystems. 2022 Oct 26;7(5):e0036422. doi: 10.1128/msystems.00364-22. Epub 2022 Aug 24.
Features of the airway microbiome in persons with cystic fibrosis (pwCF) are correlated with disease progression. Microbes have traditionally been classified for their ability to tolerate oxygen. It is unknown whether supplemental oxygen, a common medical intervention, affects the airway microbiome of pwCF. We hypothesized that hyperoxia significantly impacts the pulmonary microbiome in cystic fibrosis. In this study, we cultured spontaneously expectorated sputum from pwCF in artificial sputum medium under 21%, 50%, and 100% oxygen conditions using a previously validated model system that recapitulates microbial community composition in uncultured sputum. Culture aliquots taken at 24, 48, and 72 h, along with uncultured sputum, underwent shotgun metagenomic sequencing with absolute abundance values obtained with the use of spike-in bacteria. Raw sequencing files were processed using the bioBakery pipeline to determine changes in taxonomy, predicted function, antimicrobial resistance genes, and mobile genetic elements. Hyperoxia reduced absolute microbial load, species richness, and diversity. Hyperoxia reduced absolute abundance of specific microbes, including facultative anaerobes such as and some Streptococcus species, with minimal impact on canonical CF pathogens such as Pseudomonas aeruginosa and Staphylococcus aureus. The effect size of hyperoxia on predicted functional pathways was stronger than that on taxonomy. Large changes in microbial cooccurrence networks were noted. Hyperoxia exposure perturbs airway microbial communities in a manner well tolerated by key pathogens. Supplemental oxygen use may enable the growth of lung pathogens and should be further studied in the clinical setting. The airway microbiome in persons with cystic fibrosis (pwCF) is correlated with lung function and disease severity. Supplemental oxygen use is common in more advanced CF, yet its role in perturbing airway microbial communities is unknown. By culturing sputum samples from pwCF under normal and elevated oxygen conditions, we found that increased oxygen led to reduced total numbers and diversity of microbes, with relative sparing of common CF pathogens such as Pseudomonas aeruginosa and Staphylococcus aureus. Supplemental oxygen use may enable the growth of lung pathogens and should be further studied in the clinical setting.
囊性纤维化(CF)患者的气道微生物群特征与疾病进展相关。传统上,微生物根据其耐受氧气的能力进行分类。目前尚不清楚补充氧气(一种常见的医疗干预措施)是否会影响 CF 患者的气道微生物群。我们假设,高氧显著影响 CF 患者的肺部微生物群。在这项研究中,我们使用先前验证的模型系统,在 21%、50%和 100%的氧气条件下,在人工痰培养基中培养 CF 患者自发咳出的痰,该模型系统再现了未培养痰中的微生物群落组成。在 24、48 和 72 小时时采集培养物等分试样,并与未培养的痰一起进行 shotgun 宏基因组测序,使用掺入细菌获得绝对丰度值。使用 bioBakery 管道处理原始测序文件,以确定分类学、预测功能、抗生素耐药基因和移动遗传元件的变化。高氧降低了绝对微生物负荷、物种丰富度和多样性。高氧降低了一些兼性厌氧菌的绝对丰度,如 和一些链球菌属物种,对典型 CF 病原体如铜绿假单胞菌和金黄色葡萄球菌的影响最小。高氧对预测功能途径的影响大小强于对分类学的影响。注意到微生物共生网络的巨大变化。高氧暴露以 CF 关键病原体能够耐受的方式扰乱气道微生物群落。补充氧气的使用可能会促进肺部病原体的生长,应在临床环境中进一步研究。囊性纤维化(CF)患者的气道微生物群与肺功能和疾病严重程度相关。补充氧气在更晚期的 CF 中很常见,但它在扰乱气道微生物群方面的作用尚不清楚。通过在正常和升高的氧气条件下培养 CF 患者的痰样本,我们发现增加氧气会导致微生物总数和多样性减少,而常见 CF 病原体如铜绿假单胞菌和金黄色葡萄球菌相对较少。补充氧气的使用可能会促进肺部病原体的生长,应在临床环境中进一步研究。